Where does Bausch Health Companies's cash flow data come from?

Every line is extracted from Bausch Health Companies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Net income	——	——	-$611M-188%	-$212M+79.0%
Depreciation and amortization	$1.21B-4.7%	$1.27B+0.2%	$1.26B-9.3%	$1.39B-10.2%
Stock-based compensation	$216M+44.0%	$150M+13.6%	$132M+4.8%	$126M-1.6%
Amortization of debt issuance costs	$94M+70.9%	$55M-15.4%	$65M-34.3%	$99M+80.0%
Gain (loss) on sale of assets	$6M-40.0%	$10M—	——	$5M+150%
Change in accounts receivable	——	——	$195M+242%	$57M-75.1%
Change in inventories	——	$267M-17.1%	$322M+62.6%	$198M—
Change in accounts payable	-$76M-121%	$357M+126%	$158M—	——
Change in other assets	——	-$135M-161%	$223M—	——
Loss on extinguishment of debt	——	$23M+2,200%	$1M-99.9%	$698M+1,226%
Net cash from operating activities	$1.4B-12.3%	$1.6B+54.7%	$1.03B—	——
Capital expenditures	$397M+17.8%	$337M+56.7%	$215M-1.4%	$218M-19.0%
Proceeds from sale of businesses	$7M0.0%	$7M+40.0%	$5M0.0%	$5M-99.3%
Purchases of intangible assets	——	$3M-94.7%	$57M+14.0%	$50M+257%
Net cash from investing activities	-$595M-31.1%	-$454M+78.8%	-$2.15B-608%	-$303M—
Proceeds from issuance of debt	$10.56B+1,497%	$661M-79.9%	$3.29B-51.9%	$6.84B+225%
Repayments of debt	$11.19B+667%	$1.46B-14.6%	$1.71B-78.2%	$7.85B+128%
Taxes paid for net share settlement	$24M-7.7%	$26M+8.3%	$24M-22.6%	$31M-40.4%
Other financing activities	$26M-3.7%	$27M-22.9%	$35M+34.6%	$26M-68.7%
Payment of debt issuance costs	$45M—	——	$36M-49.3%	$71M+47.9%
Net cash from financing activities	-$742M+22.1%	-$953M-161%	$1.55B+428%	-$474M—
Effect of exchange rate changes on cash	$67M—	——	$9M—	——
Net increase (decrease) in cash	——	$239M-35.6%	$371M+123%	-$1.62B—
Allowances for losses on trade receivable and inventories	$71M+14.5%	$62M+10.7%	$56M+9.8%	$51M-15.0%
Amortization of inventory step-up resulting from acquisitions	$64M-22.0%	$82M+257%	$23M—	$0—
Non-cash interest expense	$94M+70.9%	$55M-15.4%	$65M-34.3%	$99M+80.0%
Acquisition-related contingent consideration	——	——	——	$29M+164%
Deferred income taxes	$80M+21.2%	$66M+29.4%	$51M—	——
Derivative, Gain, Excluded Component	$10M-23.1%	$13M0.0%	$13M+117%	$6M-70.0%
Foreign Currency Transaction And Other Gain (Loss), Before Tax	——	-$3M+92.7%	-$41M-1,267%	-$3M-109%
Gain (Loss) on Disposition of Assets	$6M-40.0%	$10M—	——	$5M+150%
Gain (Loss) Related To Litigation Settlement, Gross	-$61M+72.3%	-$220M-746%	-$26M-189%	-$9M+98.4%
Goodwill impairments	——	——	$493M-40.2%	$824M+75.7%
Increase (Decrease) in Prepaid Expense and Other Assets	——	-$135M-161%	$223M—	——
Payment For Contingent Consideration Liability, Including Accretion, Operating Activities	$8M-20.0%	$10M0.0%	$10M—	——
Payments for Legal Settlements	$215M-6.5%	$230M+2,200%	$10M—	——
Payments For Proceeds From Hedge Investing Activities	——	——	——	$0—
Payments To Acquire Businesses And For Other Investments	$204M+50.0%	$136M-92.8%	$1.89B+4,100%	$45M—
Payments to Acquire Intangible Assets	——	$3M-94.7%	$57M+14.0%	$50M+257%
Divestiture of businesses, net of cash transferred	$7M0.0%	$7M+40.0%	$5M0.0%	$5M-99.3%
Payments Of Debt Issuance Costs	$45M—	——	$36M-49.3%	$71M+47.9%
Other, net	-$10M+9.1%	-$11M0.0%	-$11M0.0%	-$11M—
Payment For Contingent Consideration Liability Financing Activities	$26M-3.7%	$27M-22.9%	$35M+34.6%	$26M-68.7%
Free cash flow	$1B-20.4%	$1.26B+54.2%	$817M—	——
Free cash flow	$1B-20.4%	$1.26B+54.2%	$817M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Bausch Health Companies's cash flow data come from?: Every line is extracted from Bausch Health Companies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.